Because meningococcal disease is such a serious and rapidly progressing illness, it is very important to monitor trends in the
|
|
- Nickolas Cain
- 5 years ago
- Views:
Transcription
1 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Nov. 2003, p Vol. 47, No /03/$ DOI: /AAC Copyright 2003, American Society for Microbiology. All Rights Reserved. Interlaboratory Comparison of Agar Dilution and Etest Methods for Determining the MICs of Antibiotics Used in Management of Neisseria meningitidis Infections Julio A. Vázquez, 1 * Luisa Arreaza, 1 Colin Block, 2 Ingrid Ehrhard, 3 Stephen J. Gray, 4 Sigrid Heuberger, 5 Steen Hoffmann, 6 Paula Kriz, 7 Pierre Nicolas, 8 Per Olcen, 9 Anna Skoczynska, 10 Lodewijk Spanjaard, 11 Paola Stefanelli, 12 Muhamed-Kheir Taha, 13 and Georgina Tzanakaki 14 National Institute of Health Carlos III, Majadahonda (Madrid), Spain 1 ; Hadassah University Hospital, Jerusalem, Israel 2 ; National Reference Center for Meningococci, Heidelberg, Germany 3 ; Meningococcal Reference Unit, Public Health Laboratory, Manchester, United Kingdom 4 ; Bundesstaatliche Bakterilogisch-Serologischen, Untersuchungsanstalt, Graz, Austria 5 ; Statens Serum Institute, Copenhagen S, Denmark 6 ; National Reference Laboratory for Meningococcal Infections, Prague, Czech Republic 7 ; Unite Meningocoque, WHO Collaborating Center, Marseille, France 8 ; University Hospital, Örebro, Sweden 9 ; National Reference Center for Bacterial Meningitis, National Institute of Public Health, Warsaw, Poland 10 ; Netherlands Reference Laboratory of Bacterial Meningitis, The Netherlands 11 ; Istituto Superiore di Sanitá, Rome, Italy 12 ; Institute Pasteur, Paris, France 13 ; and National School of Public Health, Athens, Greece 14 Received 7 February 2003/Returned for modification 9 June 2003/Accepted 15 July 2003 Previous studies have shown that there is considerable variation in the methods and media used to determine the susceptibility of Neisseria meningitidis to antimicrobial agents in different countries. In this study, national and regional reference laboratories used a standardized methodology to determine the MICs of antibiotics used in the management of meningococcal infection. Fourteen laboratories participated in the study, determining the susceptibility to penicillin G, rifampin, cefotaxime, ceftriaxone, ciprofloxacin, and ofloxacin of a collection of 17 meningococci, of which 11 strains were previously defined as having intermediate resistance to penicillin (Pen I ) by sequencing and restriction fragment length polymorphism analysis of the pena gene. The MIC was determined by agar dilution and Etest with Mueller-Hinton agar (MH), MH supplemented with sheep blood (MH B), and MH supplemented with heated (chocolated) blood. Several laboratories encountered problems obtaining confluent growth with unsupplemented MH. MH B was considered to give the most congruent and reproducible results among the study laboratories. The modal MIC for MH B for each antibiotic and method was calculated to define the MIC consensus, allowing assessment of each individual laboratory s data in relation to the others. The agreement in each antibiotic/method/medium combination was defined as the percentage of laboratories with a result within one dilution of the modal result. For the whole study, an agreement of 90.6% was observed between agar dilution and Etest methods. The agreement in each laboratory/antibiotic/method combination ranged from 98.2% to 69.7%, with six laboratories demonstrating agreement higher than 90% and 11 more than 80%. The ability of the laboratories to detect the Pen I isolates ranged from 18.2% to 100%. The apparent difficulty in interpreting susceptibility to rifampin, particularly with the Etest method, is very interesting. Neisseria meningitidis, the etiological agent of meningococcal disease, remains susceptible to many antimicrobial agents. Apart from resistance to sulfonamides, meningococci remain susceptible to the antibiotics classically used for treatment and chemoprophylaxis (15). But, since 1985, decreased susceptibility to penicillin caused by alterations in the penicillin-binding proteins (12) has been noted in some countries (11, 14, 15). In addition, several meningococcal strains with a high level of penicillin resistance due to beta-lactamase production have also been described (4). Resistance to rifampin is only occasionally observed, and this may be identified following chemoprophylaxis (8). Because meningococcal disease is such a serious and rapidly progressing illness, it is very important to monitor trends in the * Corresponding author. Mailing address: National Reference Laboratory for Meningococci Centro Nacional de Microbiología, National Institute of Health Carlos III, Majadahonda (Madrid), Spain. Phone: Fax: resistance to antimicrobial agents in meningococci in each country. In order to compare data between laboratories and monitor resistance trends, it is critical to use standardized protocols for the determination of susceptibility to antibiotics. The National Committee for Clinical Laboratory Standards (NCCLS) recommends a specific methodology to determine the MIC of antibiotics against meningococci (10), but breakpoints to define different categories of susceptibility have not been established. The NCCLS recommends the use of broth microdilution in cation-adjusted Mueller-Hinton (MH) broth supplemented with lysed horse blood or agar dilution with MH supplemented with sheep blood. But, the Etest method, commonly used in Europe, is a practical alternative for clinical laboratories when a quick result is clinically or epidemiologically important (9). Alternatively, the use of a disk diffusion test with 2Uofpenicillin or 1 g of oxacillin has been proposed for that purpose (7), but there is some concern about the reliability of this methodology (6), and further multicenter studies are required to clarify the use of this method. In order to identify the methodologies used for MIC deter- 3430
2 VOL. 47, 2003 DETERMINATION MIC FOR MENINGOCOCCI 3431 TABLE 1. Characteristics of the strains used in the EMGM standardization study EMGM strain no. Antigen expression a Yr of isolation mination in different countries, a questionnaire compiled by the European Monitoring Group of Meningococci (EMGM) was sent to 26 national and regional reference laboratories, including not only European centers but also laboratories in Australia, Israel, and the United States (5). The results of the questionnaire highlighted the heterogeneity of methods, particularly with regard to the media used. A similar degree of variability was also observed with respect to the breakpoints used. While susceptibility data can monitor trends within a given country or region, the lack of standardization makes it very difficult to compare susceptibility data between countries. The EMGM, during its fifth meeting in Greece in 1999, concluded that it would be useful and instructive to apply a standard methodology for determining the MICs of a panel of meningococcal strains, particularly focusing on the agar dilution and Etest methods, which, according to the results of the questionnaire, were the most frequently used across Europe. The results of the project, coordinated by the Spanish Reference Laboratory for Neisseria (SRLN), are reported in this study. MATERIALS AND METHODS Origin b 1 C:2a:P1.5, Blood 2 NG:NT:NST 1992 Nasopharynx 4 B:4:P Nasopharynx 5 B:1:NST 1999 Blood 6 B:NT:P1.3, Nasopharynx 7 B:4:P Nasopharynx 8 B:4:P Blood 9 B:4:NST 1998 CSF 10 C:2b:P1.5, Blood 11 B:NT:P CSF 12 B:1:NST 1999 Nasopharynx 13 C:2b:NST 1992 Blood 14 C:2a:P CSF 15 C:2a:P Blood 16 C:2b:NST 1992 Blood 17 B:1:NST 1999 Blood 18 C:2b:NST 1992 Blood a Serogroup/serotype/serosubtype combination. b CSF, cerebrospinal fluid. c NG, nongroupable; NT, nonserotypeable; NST, nonserosubtypeable. The SRLN prepared and distributed a collection of meningococcal strains together with 500 g of MH dehydrated medium, the antibiotics, and a protocol for performing dilutions and preparing media to determine the MICs of the strains by the agar dilution and Etest methods. The strains were tested on MH, MH supplemented with sheep blood (MH B), and MH supplemented with heated (chocolated) sheep blood (MH CH). Strains. A collection of 17 freeze-dried meningococcal strains isolated in Spain between 1992 and 1999 was prepared. The isolates, according to the data of the SRLN, represented a range of levels of susceptibility to antimicrobial agents, particularly to penicillin G and rifampin. The characteristics of these strains are shown in Table 1. Media and antibiotics. The same designated batch of MH (Oxoid, Basingstoke, Hampshire, England) was distributed to all the participating laboratories. The antibiotics to be used were chosen by consensus and included penicillin G, rifampin, ciprofloxacin, ofloxacin, cefotaxime, and ceftriaxone. Batches of antibiotics were sourced from Cepa Schwarz Pharma S.L. for ciprofloxacin and Sigma-Aldrich, Inc., for the other antibiotics. The Etest strips were obtained from the sole manufacturer (AB Biodisk, Sweden) via local suppliers by each laboratory. Protocols. Protocols for producing the dilutions and media to determine the MICs of the strains by agar dilution and Etest methods were distributed to all participating laboratories. Antimicrobial susceptibility was determined by two methods (agar dilution and Etest) with three culture media (MH, MH B, and MH CB) as previously described (5, 9). For agar dilution, the antibiotics were used in serial twofold dilutions, with concentrations ranging from to 2 g/ml for penicillin G, to 0.03 g/ml for cefotaxime, to 0.06 g/ml for ceftriaxone, to 64 g/ml for rifampin, and to 0.12 g/ml for ciprofloxacin and ofloxacin. Although the accuracy of concentrations below g/ml is not very good, a wide range of concentrations was included to be able to compare results at these low concentrations. The organisms were applied to the plates at a final concentration of 10 5 CFU per spot. After allowing the surface to absorb the inoculum, all the plates were incubated for 24 h at 35 C in5%co 2. The MIC was defined as the lowest concentration of antibiotic that prevented visible growth. For the Etest method, 0.5 McFarland standard suspensions of the test organisms were prepared and inoculated onto the plate with a nontoxic swab to produce confluent growth. Etest strips containing the antimicrobial agent were placed on the inoculated plates with sterile forceps. Some laboratories used 150-mm plates, placing all six strips on it; others used 90-mm plates, placing two strips in each; but most of the laboratories used 90-mm plates, placing only one Etest strip in each. The plates were incubated for 24 h at 35 C in5%co 2 and then the MICs were determined according to the manufacturer s instructions. Each laboratory used its own method to determine the inoculum concentration for the 10 5 CFU per spot and 0.5 McFarland. Sequence analysis and RFLP of the pena gene. Because intermediate resistance to penicillin is produced by alterations in PBP2, encoded by the pena gene, this gene was sequenced, by the SRLN, in all 17 strains as previously described (3). The Institute Pasteur also analyzed the pena gene by restriction fragment length polymorphism (RFLP) according to a published method (1). Analysis of the data. All the data were included in a Microsoft Excel file, and the analysis was done with this software. The congruence of the data was analyzed to identify the optimal medium. For this purpose, the agreement in each antibiotic/method/medium combination was defined as the percentage of laboratories with a result within one dilution of the modal result. The modal result was calculated for each strain against each antibiotic with the TABLE 2. Agreement obtained in each antibiotic/method/medium combination a Drug Method Agreement (%) MH MH B MH CH Penicillin AD Etest Rifampin AD Etest Ciprofloxacin AD Etest Ofloxacin AD Etest Cefotaxime AD Etest Ceftriaxone AD Etest ND ND ND Total AD Etest a The highest percentage of coincident MICs among all participating laboratories. The best agreement in each case is in italics. Two or three different media in bold for the same antibiotic and method indicates that differences were not statistically significant. ND, not determined; AD, agar dilution.
3 3432 VÁZQUEZ ET AL. ANTIMICROB. AGENTS CHEMOTHER. TABLE 3. Modal MICs obtained in MH B for the both, agar dilution, and Etest methods a Modal MIC ( g/ml) EMGM strain no. Method Penicillin G Rifampin Cefotaxime Ceftriaxone Ciprofloxacin Ofloxacin 1 AD Etest AD Etest AD Etest * AD Etest * AD Etest * AD Etest * AD Etest * AD Etest * AD Etest AD Etest * AD Etest * AD Etest AD Etest * AD Etest * AD Etest AD Etest * AD Etest a Results differing by more than 1 dilution comparing agar dilution with Etest are in italics. *, strains identified as being intermediate to penicillin by sequencing of the pena gene and RFLP. most optimal medium. These modal results defined the MIC for each strain/ antibiotic combination. Two results were considered coincident (the same) if they were within 1 dilution. RESULTS The agreement for each antibiotic/method/medium combination is shown in Table 2. The agreement was very similar in MH B and MH CH media, but overall, MH B offered the best agreement, being the medium with the most homogeneous results among laboratories, and was therefore adopted TABLE 4. Agreement obtained between the agar dilution and Etest methods for the determination of the consensus MIC of each antibiotic a Antibiotic Agreement (%) Penicillin G Rifampin Ciprofloxacin Ofloxacin Cefotaxime Total a Ceftriaxone is not included because the MIC was not determined by Etest.
4 VOL. 47, 2003 DETERMINATION MIC FOR MENINGOCOCCI 3433 TABLE 5. Agreement for each laboratory/antibiotic/method combination a Agreement (%) Laboratory no. Penicillin G Rifampicin Ciprofloxacin Ofloxacin Cefotaxime AD Etest AD Etest AD Etest AD Etest AD Etest for most of the analyses. Three laboratories experienced difficulty obtaining confluent growth with MH. No laboratories reported difficulties in the interpretation of the Etest method. We were unable to analyze the agreement for ceftriaxone with the Etest because all the strains had MICs lower than the minimum ( g/ml) present on the Etest strips. The MICs obtained by calculating the modal result in MH B are shown in Table 3. The MICs were called the MIC consensus. The MIC was not calculated for ceftriaxone with Etest for the reason stated previously. An agreement of 90.6% was observed between the agar dilution and Etest methods (Table 4). The best agreement was observed with penicillin G, ciprofloxacin, and cefotaxime. The agreement of each laboratory/antibiotic/method combination is shown in Table 5. The results for each antibiotic were heterogeneous, with some laboratories showing large variations in agreement; laboratory number 12 ranged from 23.5% to 100%, and laboratories 2 and 9 ranged from 41.2% to 100%. The most homogeneous results were obtained by laboratory 8 (Table 5). Of note was the apparent difficulty in determining susceptibility to rifampin, particularly with the Etest method. In fact, no laboratory obtained a 100% agreement in this antibiotic/method combination (Table 5). The worst results (obtained by laboratories 5 and 14) were in determining MICs of ceftriaxone in agar dilution (Table 5); but, this antibiotic/ method combination offered very good and homogeneous results in the other laboratories, even at very low concentrations. Comparing the penicillin MICs with sequencing and RFLP analysis of the pena gene, 11 meningococci of the collection were defined as having intermediate resistance to penicillin (Pen I ). This information was used to analyze the ability of the laboratories to detect Pen I strains. The meningococci identified as intermediate were those numbered EMGM 5, 6, 7, 8, 9, 10, 12, 13, 15, 16, and 18. If we accept that the Pen I strains are those defined by sequence/rflp of the pena gene, only three laboratories were able to detect all of these meningococci by the agar dilution and Etest methods. One laboratory was unable to detect five (45.4%) intermediate strains by agar dilution, while another detected only two (18.2%). The MICs of penicillin were found to be higher than 0.06 g/ml (the breakpoint used to define intermediate resistance) for all strains previously defined as Pen I meningococci except strain EMGM5 (Table 3). Strain EMGM5, assigned a MIC consensus corresponding to a susceptible isolate, was the most difficult to determine as Pen I. DISCUSSION Ceftriaxone (AD) a AD, agar dilution;, MICs not determined.. Three laboratories reported problems obtaining confluent growth in MH without supplement. MH B and MH CH gave very similar results of general agreement (Table 2), but MH B is easier to prepare and additionally gave the results closest to the consensus overall in each antibiotic/method combination. We therefore recommend the use of MH (or some other proper basal medium) supplemented with 5% blood for the routine determination of MICs for N. meningitidis. Several laboratories used their own basal medium, and the results were comparable (data not showed). The agreement between the agar dilution and Etest methods was good, being 100% for penicillin G (Table 4). This is a very important finding because many laboratories use the Etest method as the routine method to determine the MIC for meningococcal strains (5). This would allow accurate comparison of the incidence of Pen I isolates between laboratories using different methods. One group detected unusual patterns of growth along the Etest strips, and that finding might have made it more difficult to determine the MIC for the strains showing that phenomena. The agreement between agar dilution and Etest was worse with ofloxacin and rifampin, but the discrepancies were very close to the range of 1 dilution difference. This finding is very important for rifampin, because the discrepancies were found in strains with very low MICs (EMGM 11, EMGM 12) and also those showing resistance (EMGM 16) (Table 3). However, both methods defined the same strains as resistant or susceptible to rifampin, so the discrepancies may affect the epidemiological surveillance trends but not the clinical information. All the strains showed a high level of susceptibility to ofloxacin, so
5 3434 VÁZQUEZ ET AL. ANTIMICROB. AGENTS CHEMOTHER. we could not compare the sensitivity of each method in detectong different levels of susceptibility. The comparison between the agar dilution and Etest methods will be interesting to study further if strains showing decreased susceptibility to that antimicrobial agent appear (13). There was one strain (EMGM 5) possessing a sequence typical of a Pen I isolate that demonstrated a MIC consensus inside the susceptibility range with both methods (Table 3). The study shows a limitation at this level: no strains with a MIC of g/ml by Etest were included. The NCCLS does not specify the breakpoint to define the susceptibility levels of penicillin with microdilution or macrodilution, but those described for Neisseria gonorrhoeae have been used for meningococci (2). These breakpoints are 0.06 g/ml for susceptible, 0.12 to 1 g/ml for intermediate, and 2 g/ml for resistant strains (10). Both methods (microdilution and agar dilution) are based on a range of doubling dilutions. With those breakpoint definitions, there will be several gaps by Etest, and strains with MICs of g/ml or between 1 and 2 g/ml might be misclassified. The definition of the breakpoints to be used to define different levels of susceptibility should take into account the possibility that Etest will be used. In the same way, it is very important that all laboratories work with the same range of doubling dilutions in order to apply definite categories. To this end, the range of doubling dilutions that allow the classification of the strains according to breakpoints defined for gonococci by the NCCLS should be used (10). Because the main area of concern with meningococci is intermediate resistance to penicillin, most of the study was focused on the ability of each laboratory to detect this level of resistance. Ten strains were defined as Pen I according to the common definition. But the only mechanism well known to increase the level of resistance is genetic modification in the pena gene. The sequence of this gene and the RFLP patterns of the gene allowed us to identify 11 Pen I meningococci. No isolate with a sequence characteristic of susceptible strains presented a MIC consensus higher than 0.06 g/ml, so we do not think that mechanisms other than the modification of the pena gene contribute to this intermediate resistance level. The EMGM 5 strain, well defined as intermediate by the sequence or RFLP pattern, had a MIC consensus of 0.06 g/ml by the agar dilution and g/ml by the Etest method (Table 3). The real MIC of this strain should be close to 0.1 g/ml; in fact, five laboratories found MICs higher than 0.06 g/ml by Etest, ranging between and g/ml. The development of a molecular approach to define and determine a Pen I strain may be warranted. This panel of serologically well defined meningococci with known penicillin resistance determinants could be used in further studies to define quality control limits and MIC breakpoints for meningococci. We propose the use of four isolates with a high agreement between laboratories (EMGM 1, 2, 10, and 13) as the basis of a strain collection to make available for use by others working in the field of meningococcal antibiotic resistance. These isolates belong to the EMGM and are kept at the Spanish Reference Laboratory for Meningococci (National Institute of Health Carlos III), where they can be obtained by request. ACKNOWLEDGMENTS This work was supported by grant QLK2-CT from the European Commission. The large number of laboratories working on this project makes it difficult to include everybody who might sign this paper. We thank Laura de la Fuente (Instituto de Salud Carlos III, Spain), Gillian Smollan (Hadassah University Hospital, Israel), Lene Berthelsen (Statens Serum Institute, Denmark), Paula Urbaskova (National Reference Laboratory for Antibiotics, Czech Republic), and Cecilia Fazio (Istituto Superiore di Sanitá, Italy) for their collaboration. REFERENCES 1. Antignac, A., J. M. Alonso, and M. K. Taha Nonculture prediction of Neisseria meningitidis susceptibility to penicillin. Antimicrob. Agents Chemother. 45: Arreaza, L., L. De La Fuente, and J. A. Vázquez Antibiotic susceptibility patterns of Neisseria meningitidis isolated from patients and asymptomatic carriers. Antimicrob. Agents Chemother. 44: Arreaza, L., and J. A. Vázquez Molecular approach for the study of penicillin resistance in Neisseria meningitidis,p In A. J. Pollard and M. C. J. Maiden (ed.), Meningococcal disease. Methods and protocols. Humana Press, Totowa, N.J. 4. Bäckman, A., P. Orverlid, J. A. Vázquez, O. Sköld, and P. Olcén Complete sequence of a beta-lactamase encoding plasmid in Neisseria meningitidis. Antimicrob. Agents Chemother. 44: Block, C Antibiotics susceptibility testing, p In A. J. Pollard and M. C. J. Maiden (ed.), Meningococcal disease. Methods and protocols. Humana Press, Totowa, N.J. 6. Block, C., Y. Davidson, and N. Keller Unreliability of disc diffusion test for screening for reduced penicillin susceptibility in Neisseria meningitidis. J. Clin. Microbiol. 36: Campos, J., P. M. Mendelman, M. U. Sako, D. O. Chaffin, A. L. Smith, and J. A. Sáez Nieto Detection of relatively penicillin G resistant Neisseria meningitidis by disc susceptibility testing. Antimicrob. Agents Chemother. 31: Cuevas, L. E., and C. A. Hart Chemoprophylaxis of bacterial meningitis. J. Antimicrob. Chemother. 31(Suppl. B): Hughes, J. H., D. J. Biedenbach, M. E. Erwin, and R. N. Jones E test as susceptibility test and epidemiologic tool for evaluation of Neisseria meningitidis isolates. J. Clin. Microbiol. 31: National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing; eleventh informational supplement. NCCLS document M100-S13. National Committee for Clinical Laboratory Standards, Wayne, Pa. 11. Richter, S. S., K. A. Gordon, P. R. Rhomberg, M. A. Pfaller, and R. N. Jones Neisseria meningitidis with decreased susceptibility to penicillin: report from the SENTRY antimicrobial surveillance program, North America, Diagn. Microbiol. Infect. Dis. 41: Sáez-Nieto, J. A., R. Lujan, S. Berrón, J. Campos, M. Viñas, C. Fusté, J.A. Vázquez, Q. Y. Zhang, L. D. Bowler, J. V. Martinez Suárez, and B. G. Spratt Epidemiology and molecular basis of penicillin resistant Neisseria meningitidis in Spain: a five year history ( ). Clin. Infect. Dis. 14: Shultz, T. R., J. W. Tapsall, P. A. White, and P. J. Newton An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones. Antimicrob. Agents Chemother. 44: Tapsall, J. W., T. Shultz, E. Limnios, R. Munro, J. Mercer, R. Porritt, J. Griffith, G. Hogg, G. Lum, A. Lawrence, D. Hansman, P. Collignon, P. Southwell, K. Ott, M. Gardam, C. J. Richardson, J. Bates, D. Murphy, and H. Smith Surveillance of antibiotic resistance in invasive isolates of Neisseria meningitidis in Australia Pathology 33: Vázquez, J. A The resistance of Neisseria meningitidis to the antimicrobial agents: an issue still in evolution. Rev. Med. Microbiol. 12:39 45.
Neisseria meningitidis ANTIMICROBIAL RESISTANCE:CURRENT SITUATION IN LATIN AMERICA AND ITS CLINICAL RELEVANCE
Neisseria meningitidis ANTIMICROBIAL RESISTANCE:CURRENT SITUATION IN LATIN AMERICA AND ITS CLINICAL RELEVANCE Dra. Silvia E. González Ayala Head Professor Cátedra Infectología, Facultad Ciencias Médicas,
More informationEDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update
EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain
More informationPushpa Bhawan Mal 1, Kauser Jabeen 1*, Joveria Farooqi 1, Magnus Unemo 2 and Erum Khan 1
Mal et al. BMC Microbiology (2016) 16:236 DOI 10.1186/s12866-016-0707-6 RESEARCH ARTICLE Open Access Antimicrobial susceptibility testing of Neisseria gonorrhoeae isolates in Pakistan by Etest compared
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationAPPENDIX III - DOUBLE DISK TEST FOR ESBL
Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January
More informationAnnual Report: Table 1. Antimicrobial Susceptibility Results for 2,488 Isolates of S. pneumoniae Collected Nationally, 2005 MIC (µg/ml)
Streptococcus pneumoniae Annual Report: 5 In 5, a total of, isolates of pneumococci were collected from 59 clinical microbiology laboratories across Canada. Of these, 733 (9.5%) were isolated from blood
More informationBrief reports. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae
Journal of Antimicrobial Chemotherapy (1997) 40, 105 108 Brief reports JAC Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae Andreas Pikis a *, Jacob A. Donkersloot
More informationAntimicrobial susceptibility testing of Campylobacter jejuni and C. coli
Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli CRL Campylobacter Workshop The 7th -8th of Oct. 2008 National Veterinary Institute Uppsala, Sweden Legislation The Commission has
More informationEvaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals
J Vet Diagn Invest :164 168 (1998) Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals Susannah K. Hubert, Phouc Dinh Nguyen, Robert D. Walker Abstract.
More informationReceived 10 November 2006/Returned for modification 9 January 2007/Accepted 17 July 2007
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Oct. 2007, p. 3726 3730 Vol. 51, No. 10 0066-4804/07/$08.00 0 doi:10.1128/aac.01406-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Comparative
More informationAntimicrobial susceptibility testing of Campylobacter jejuni and C. coli. CRL Training course in AST Copenhagen, Denmark 23-27th Feb.
Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli CRL Training course in AST Copenhagen, Denmark 23-27th Feb. 2009 Methodologies E-test by AB-biodisk A dilution test based on the
More informationEuropean Antimicrobial Resistance Surveillance System (EARSS) in Scotland: 2004
European Antimicrobial Resistance Surveillance System (EARSS) in Scotland: 2004 SECOND ANNUAL REPORT MJ Coyne 1, SJ Dancer 1, G Edwards 2, 3, D Morrison 2. 1 Health Protection Scotland, 2 Scottish MRSA
More informationVikram Singh, Manju Bala, Monika Kakran, V Ramesh
Open Access To cite: Singh V, Bala M, Kakran M, et al. Comparative assessment of CDS, CLSI disc diffusion and Etest techniques for antimicrobial susceptibility testing of Neisseria gonorrhoeae: a 6-year
More informationQuality assurance of antimicrobial susceptibility testing
Quality assurance of antimicrobial susceptibility testing Derek Brown Routine quality control Repeated testing of controls in parallel with tests to ensure that the test system is performing reproducibly
More informationStreptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance
Streptococcus pneumoniae Oxacillin µg as screen for beta-lactam resistance Version 6. June Streptococcus pneumoniae and zone diameter correlates The following histograms present inhibition zone diameter
More informationSAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals
VET01 5th Edition Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals This standard covers the current recommended methods for disk diffusion
More informationPILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 1996
PILOT STUDY OF THE ANTIMICROBIAL SUSCEPTIBILITY OF SHIGELLA IN NEW ZEALAND IN 996 November 996 by Maggie Brett Antibiotic Reference Laboratory ESR Communicable Disease Centre Porirua CONTENTS Page SUMMARY
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationORIGINAL ARTICLE. Focus Technologies, Inc., 1 Hilversum, The Netherlands, 2 Herndon, Virginia and 3 Franklin, Tennessee, USA
ORIGINAL ARTICLE In vitro susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: a European multicenter study during 2000 2001 M. E. Jones 1, R. S. Blosser-Middleton
More informationPneumococcus: Antibiotic Resistance in the Region
Pneumococcus: Antibiotic Resistance in the Region Çiğdem Bal Kayacan Istanbul University Istanbul Faculty of Medicine Department of Microbiology & Clinical Microbiology Drug Resistance in S.pneumoniae
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationTel: Fax:
CONCISE COMMUNICATION Bactericidal activity and synergy studies of BAL,a novel pyrrolidinone--ylidenemethyl cephem,tested against streptococci, enterococci and methicillin-resistant staphylococci L. M.
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More informationDetection of Methicillin Resistant Strains of Staphylococcus aureus Using Phenotypic and Genotypic Methods in a Tertiary Care Hospital
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 7 (2017) pp. 4008-4014 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.607.415
More informationUse of the National Committee for Clinical Laboratory Standards Guidelines for Disk Diffusion Susceptibility Testing in New York State Laboratories
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2000, p. 3341 3348 Vol. 38, No. 9 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Use of the National Committee for
More informationOriginal Article. Suthan Srisangkaew, M.D. Malai Vorachit, D.Sc.
Original Article Vol. 21 No.1 The optimum agent for ESBL screening and confirmatory tests:- Srisangkaew S & Vorachit M. 1 The Optimum Agent for Screening and Confirmatory Tests for Extended-Spectrum Beta-Lactamases
More informationBackground and Plan of Analysis
ENTEROCOCCI Background and Plan of Analysis UR-11 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony count, to perform the identification
More informationShould we test Clostridium difficile for antimicrobial resistance? by author
Should we test Clostridium difficile for antimicrobial resistance? Paola Mastrantonio Department of Infectious Diseases Istituto Superiore di Sanità, Rome,Italy Clostridium difficile infection (CDI) (first
More informationIn Vitro Antimicrobial Activity of CP-99,219, a Novel Azabicyclo-Naphthyridone
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 39-353 0066-0/93/0039-05$0.00/0 Copyright 993, American Society for Microbiology Vol. 37, No. In Vitro Antimicrobial Activity of, a Novel Azabicyclo-Naphthyridone
More informationMRSA surveillance 2014: Poultry
Vicky Jasson MRSA surveillance 2014: Poultry 1. Introduction In the framework of the FASFC surveillance, a surveillance of MRSA in poultry has been executed in order to determine the prevalence and diversity
More informationTowards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST)
Towards Rational International Antibiotic Breakpoints: Actions from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) A report to ISC presented by Paul M. Tulkens representative of
More informationOriginal Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**
Original Article In Vitro Activity of Cefminox and Other β-lactam Antibiotics Against Clinical Isolates of Extended- Spectrum-β-lactamase-Producing Klebsiella pneumoniae and Escherichia coli Ratri Hortiwakul,
More informationPrinciples and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013
Principles and Practice of Antimicrobial Susceptibility Testing Microbiology Technical Workshop 25 th September 2013 Scope History Why Perform Antimicrobial Susceptibility Testing? How to Perform an Antimicrobial
More informationEvaluation of MicroScan MIC Panels for Detection of
JOURNAL OF CLINICAL MICROBIOLOGY, May 1988, p. 816-820 Vol. 26, No. 5 0095-1137/88/050816-05$02.00/0 Copyright 1988, American Society for Microbiology Evaluation of MicroScan MIC Panels for Detection of
More informationUvA-DARE (Digital Academic Repository)
UvA-DARE (Digital Academic Repository) Antimicrobial susceptibility of Haemophilus influenzae, Neisseria meningitidis and Streptococcus pneumoniae isolates causing meningitis in the Netherlands 1993-1994
More informationagainst Clinical Isolates of Gram-Positive Bacteria
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 993, p. 366-370 Vol. 37, No. 0066-0/93/00366-05$0.00/0 Copyright 993, American Society for Microbiology In Vitro Activity of CP-99,9, a New Fluoroquinolone,
More informationEUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)
EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) Christian G. Giske, MD/PhD Chairman of ESDReM Karolinska University Hospital and EUCAST ECCMID, 22 maj 2013 The background Guidance on
More information2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)
Key words I μ μ μ μ μ μ μ μ μ μ μ μ μ μ II Fig. 1. Microdilution plate. The dilution step of the antimicrobial agent is prepared in the -well microplate. Serial twofold dilution were prepared according
More informationThere are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
ANTIMICROBIAL SUSCEPTIBILITY TESTING ON MILK SAMPLES Method and guidelines There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility
More informationCLSI vs. EUCAST. What is EUCAST? Structure of EUCAST CLSI. Where they fit? SASCM WORKSHOP 5/24/2014
vs. Olga Perovic, Principal Pathologist, Center for Opportunistic, Tropical and Hospital Infections, Associate Professor at WITS, Saturday, May 24, 2014 A not-for-profit membership organization, the Clinical
More informationESCMID Online Lecture Library. by author
Quality Assurance of antimicrobial susceptibility testing Derek Brown EUCAST Scientific Secretary ESCMID Postgraduate Education Course, Linz, 17 September 2014 Quality Assurance The total process by which
More informationEDUCATIONAL COMMENTARY CURRENT METHODS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING
Commentary provided by: Linsey Donner, MPH, CPH, MLS (ASCP) CM Assistant Professor, Microbiology and Serology College of Allied Health Professions, Division of Medical Laboratory Science University of
More informationAbstract... i. Committee Membership... iii. Foreword... vii. 1 Scope Definitions... 1
Vol. 28 No. 7 Replaces M37-A2 Vol. 22 No. 7 Development of In Vitro Susceptibility Testing Criteria and Quality Control Parameters for Veterinary Antimicrobial Agents; Approved Guideline Third Edition
More informationReceived 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 3112 3118 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.3112 3118.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationDetermination of antibiotic sensitivities by the
Journal of Clinical Pathology, 1978, 31, 531-535 Determination of antibiotic sensitivities by the Sensititre system IAN PHILLIPS, CHRISTINE WARREN, AND PAMELA M. WATERWORTH From the Department of Microbiology,
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union November 2012 Highlights on antibiotic consumption Antibiotic use is one of the main factors responsible for the development and
More informationMethod Preferences and Test Accuracy of Antimicrobial Susceptibility Testing
Method Preferences and Test Accuracy of Antimicrobial Susceptibility Testing Updates From the College of American Pathologists Microbiology Surveys Program (2000) Ronald N. Jones, MD; for the College of
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationMonitoring gonococcal antimicrobial susceptibility
Monitoring gonococcal antimicrobial susceptibility The rapidly changing antimicrobial susceptibility of Neisseria gonorrhoeae has created an important public health problem. Because of widespread resistance
More informationDefining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing
Infect Dis Ther (2015) 4:513 518 DOI 10.1007/s40121-015-0094-6 BRIEF REPORT Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationAntimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years
Journal of Antimicrobial Chemotherapy (2006) 57, 775 779 doi:10.1093/jac/dkl040 Advance Access publication 21 February 2006 Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the
More informationChristiane Gaudreau* and Huguette Gilbert
Journal of Antimicrobial Chemotherapy (1997) 39, 707 712 JAC Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter
More informationPerformance Information. Vet use only
Performance Information Vet use only Performance of plates read manually was measured in three sites. Each centre tested Enterobacteriaceae, streptococci, staphylococci and pseudomonas-like organisms.
More informationSurveillance and outbreak reports The European gonococcal antimicrobial surveillance programme, 2009
Surveillance and outbreak reports The European gonococcal antimicrobial surveillance programme, 2009 M J Cole (michelle.cole@hpa.org.uk) 1, M Unemo 2, S Hoffmann 3, S A Chisholm 1, C A Ison 1, M J van
More informationDetection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran
Letter to the Editor Detection and Quantitation of the Etiologic Agents of Ventilator Associated Pneumonia in Endotracheal Tube Aspirates From Patients in Iran Mohammad Rahbar, PhD; Massoud Hajia, PhD
More informationEUCAST Workshop: Antimicrobial susceptibility testing with EUCAST breakpoints and methods
EUCAST Workshop: Antimicrobial susceptibility testing with EUCAST breakpoints and methods Susceptibility testing of infrequently isolated fastidious organisms Luis Martinez-Martínez Service of Microbiology
More informationOvernight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients
TABLE 1. Origin and carbapenem resistance characteristics of the 64 Acinetobacter baumannii stock D-750 Overnight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients
More informationPresence of extended spectrum β-lactamase producing Escherichia coli in
1 2 Presence of extended spectrum β-lactamase producing Escherichia coli in wild geese 3 4 5 A. Garmyn* 1, F. Haesebrouck 1, T. Hellebuyck 1, A. Smet 1, F. Pasmans 1, P. Butaye 2, A. Martel 1 6 7 8 9 10
More informationSusceptibility Tests for Methicillin-Resistant (Heteroresistant) Staphylococci
JOURNAL OF CLNCAL MCROBOLOGY, Apr. 1984, p. 482-488 95-1137/84/4482-7$2./ Copyright C) 1984, American Society for Microbiology Vol. 19, No. 4 New Recommendations for Disk Diffusion Antimicrobial Susceptibility
More informationPractical approach to Antimicrobial susceptibility testing (AST) and quality control
Practical approach to Antimicrobial susceptibility testing (AST) and quality control A/Professor John Ferguson, Microbiologist & Infectious Diseases Physician, Pathology North, University of Newcastle,
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimum Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) Broth dilution: cation-adjusted Mueller-Hinton
More information56 Clinical and Laboratory Standards Institute. All rights reserved.
Table 2C 56 Clinical and Laboratory Standards Institute. All rights reserved. Table 2C. Zone Diameter and Minimal Inhibitory Concentration Breakpoints for Testing Conditions Medium: Inoculum: diffusion:
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More informationPROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains
PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains 1 INTRODUCTION... 1 2 OBJECTIVES... 2 3 OUTLINE OF THE EQAS 2017... 2 3.1 Shipping, receipt and storage of strains...
More informationOriginal Article. Suwanna Trakulsomboon, Ph.D., Visanu Thamlikitkul, M.D.
Original Article Vol. 25 No. 2 In vitro activity of daptomycin against MRSA:Trakulsomboon S & Thamlikitkul V. 57 In Vitro Activity of Daptomycin against Methicillin- Resistant Staphylococcus aureus (MRSA)
More informationReceived 19 December 2005/Returned for modification 22 February 2006/Accepted 3 May 2006
JOURNAL OF CLINICAL MICROBIOLOGY, Sept. 2006, p. 3346 3351 Vol. 44, No. 9 0095-1137/06/$08.00 0 doi:10.1128/jcm.02631-05 Copyright 2006, American Society for Microbiology. All Rights Reserved. As a Bacterial
More informationMili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh
Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original
More informationMultiple drug resistance pattern in Urinary Tract Infection patients in Aligarh
Multiple drug resistance pattern in Urinary Tract Infection patients in Aligarh Author(s): Asad U Khan and Mohd S Zaman Vol. 17, No. 3 (2006-09 - 2006-12) Biomedical Research 2006; 17 (3): 179-181 Asad
More informationENTEROCOCCI. April Abbott Deaconess Health System Evansville, IN
ENTEROCOCCI April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic antimicrobial susceptibility principles and resistance mechanisms for Enterococcus Describe issues surrounding AST
More informationEmerging cephalosporin and multidrug-resistant gonorrhoea in Europe
Surveillance and outbreak reports Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe M J Cole (michelle.cole@phe.gov.uk) 1, G Spiteri 2, S A Chisholm 2, S Hoffmann 3, C A Ison 1, M Unemo
More informationAntibacterial susceptibility testing
Antibiotics: Antil susceptibility testing are natural chemical substances produced by certain groups of microorganisms (fungi, ) that inhibit the growth of or kill the other that cause infection. Several
More informationJasmine M. Chaitram, 1,2 * Laura A. Jevitt, 1,2 Sara Lary, 1,2 Fred C. Tenover, 1,2 and The WHO Antimicrobial Resistance Group 3,4
JOURNAL OF CLINICAL MICROBIOLOGY, June 2003, p. 2372 2377 Vol. 41, No. 6 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.6.2372 2377.2003 The World Health Organization s External Quality Assurance System Proficiency
More informationAmoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate. Amoxicillin trihydrate
Annex I List of the names, pharmaceutical form, strength of the veterinary medicinal product, animal species, route of administration, applicant in the Member States Member State EU/EEA Applicant Name
More informationAntibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
Antimicrobial susceptibility of Shigella, 2015 and 2016 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
More informationThe Threat of Multidrug Resistant Neisseria gonorrhoeae
The Threat of Multidrug Resistant Neisseria gonorrhoeae Peel Public Health Symposium Sex, Drugs, and. Vanessa Allen, MD MPH October 16, 2012 The threat of multidrug resistant gonorrhea "We're sitting on
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite
More informationAnaerobe bakterier og resistens. Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark
Anaerobe bakterier og resistens Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark Programme anaerobic bacteria Carbapenem and metronidazole resistance New
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
More informationISO INTERNATIONAL STANDARD
ITERATIOAL STADARD ISO 20776-2 First edition 2007-07-01 Clinical laboratory testing and in vitro diagnostic test systems Susceptibility testing of infectious agents and evaluation of performance of antimicrobial
More informationUnderstanding the Hospital Antibiogram
Understanding the Hospital Antibiogram Sharon Erdman, PharmD Clinical Professor Purdue University College of Pharmacy Infectious Diseases Clinical Pharmacist Eskenazi Health 5 Understanding the Hospital
More informationA review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe
Journal of Antimicrobial Chemotherapy (1991) 28, Suppl. C, 31-38 A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe F. Baqoero*, J. Martfnez-Beltran and E. Loza Servicio de
More informationSynergy of Daptomycin with Oxacillin and Other -Lactams against Methicillin-Resistant Staphylococcus aureus
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2004, p. 2871 2875 Vol. 48, No. 8 0066-4804/04/$08.00 0 DOI: 10.1128/AAC.48.8.2871 2875.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved.
More informationJan A. Jacobs* and Ellen E. Stobberingh
Journal of Antimicrobial Chemotherapy (996) 37, 37-375 In-vitro antimicrobial susceptibility of the 'Streptococcus millerv group {Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius)
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/26062
More informationAntimicrobial resistance (EARS-Net)
SURVEILLANCE REPORT Annual Epidemiological Report for 2014 Antimicrobial resistance (EARS-Net) Key facts Over the last four years (2011 to 2014), the percentages of Klebsiella pneumoniae resistant to fluoroquinolones,
More informationEUCAST-and CLSI potency NEO-SENSITABS
EUCASTand CLSI potency NEOSENSITABS Neo Sensitabs Page 1 / 6 Document: 6.2.0 Fastidious organisms EUCAST Interpretation zones and MIC breakpoints according to recommendations by the "Comité de l'antibiogramme
More informationPenicillin, and Rifampin
Appum MCROBoLOGY, Dec. 970, p. 89-898 Copyright @ 970 American Society for Microbiology Vol. 0, No. Printed in U.S.A. Susceptibility of Neisseria meningitidis Strains from the Civilian Population to Sulfadiazine,
More informationand Health Sciences, Wayne State University and Detroit Receiving Hospital, Detroit, MI, USA
Journal of Antimicrobial Chemotherapy (2004) 54, Suppl. S1, i7 i15 DOI: 10.1093/jac/dkh313 JAC Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae
More informationComparison of Antimicrobial Susceptibility Testing of Campylobacter spp. by the Agar Dilution and the Agar Disk Diffusion Methods
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2007, p. 590 594 Vol. 45, No. 2 0095-1137/07/$08.00 0 doi:10.1128/jcm.00986-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. Comparison
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationRESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN
RESISTANCE OF STAPHYLOCOCCUS AUREUS TO VANCOMYCIN IN ZARQA, JORDAN Hussein Azzam Bataineh 1 ABSTRACT Background: Vancomycin has been widely used in the treatment of infections caused by Methicillin-Resistant
More informationESCMID Online Lecture Library. by author
EUCAST and susceptibility testing Europe and beyond Gunnar Kahlmeter EUCAST, ESCMID Antimicrobial susceptibility testing To guide therapy and predict clinical outcome in individual patients (clinical breakpoints)
More informationORIGINAL ARTICLE. influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.
ORIGINAL ARTICLE Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997 98 I. A. Critchley 1, C. Thornsberry
More informationResistance Among Streptococcus pneumoniae: Patterns, Mechanisms, Interpreting the Breakpoints
...PRESENTATIONS... Resistance Among Streptococcus pneumoniae: Patterns, Mechanisms, Interpreting the Breakpoints Angela B. Brueggemann, MS; and Gary V. Doern, PhD Presentation Summary Streptococcus pneumoniae
More informationThe evolutionary epidemiology of antibiotic resistance evolution
The evolutionary epidemiology of antibiotic resistance evolution François Blanquart, CNRS Stochastic Models for the Inference of Life Evolution CIRB Collège de France Quantitative Evolutionary Microbiology
More informationVersion 1.01 (01/10/2016)
CHN58: ANTIMICROBIAL SUSCEPTIBILITY TESTING (CLSI) 1.0 PURPOSE / INTRODUCTION: 1.1 Introduction Antimicrobial susceptibility tests are performed in order to determine whether a pathogen is likely to be
More informationQuelle politique antibiotique pour l Europe? Dominique L. Monnet
Quelle politique antibiotique pour l Europe? Dominique L. Monnet National Center for Antimicrobials & Infection Control Statens Serum Institut, Copenhagen, Denmark Opinion of the Section for Protection
More informationOriginal Article. Hossein Khalili a*, Rasool Soltani b, Sorrosh Negahban c, Alireza Abdollahi d and Keirollah Gholami e.
Iranian Journal of Pharmaceutical Research (22), (2): 559-563 Received: January 2 Accepted: June 2 Copyright 22 by School of Pharmacy Shaheed Beheshti University of Medical Sciences and Health Services
More information